Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

PDE IV inhibitors focus of attention at recent respiratory care congress

May 7, 1998

Phosphodiesterase inhibitors with antiasthmatic efficacy

May 7, 1998

CytoMed's 5-LO inhibitor shows potential in asthma; clinical trials imminent

May 6, 1998

SB-240563, an anti-IL-5 MAb for the treatment of asthma

May 6, 1998

Spotlight on P2Y2 agonists: a new target for cystic fibrosis

May 6, 1998

Surfaxin as ARDS treatment enters phase II/III

May 5, 1998

Nebulized furosemide beneficial in patients with acute asthma of short-term duration

May 4, 1998

AxyS Pharmaceuticals' APC-366 shows good antiasthmatic activity in phase IIa trial

May 1, 1998

New PDE IV inhibitors for asthma reported by Celltech

April 30, 1998

Astra obtains rights from Takeda to develop TxA2 antagonist

April 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...